Alphatec Holdings, Inc. $ATEC Shares Acquired by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd grew its stake in Alphatec Holdings, Inc. (NASDAQ:ATEC) by 119.2% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 165,179 shares of the medical technology company’s stock after purchasing an additional 89,814 shares during the period. Y Intercept Hong Kong Ltd owned approximately 0.11% of Alphatec worth $1,797,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently made changes to their positions in ATEC. Creative Planning lifted its position in Alphatec by 0.9% during the third quarter. Creative Planning now owns 58,654 shares of the medical technology company’s stock worth $853,000 after buying an additional 534 shares in the last quarter. Great Lakes Advisors LLC grew its holdings in Alphatec by 0.4% in the 4th quarter. Great Lakes Advisors LLC now owns 278,717 shares of the medical technology company’s stock valued at $5,864,000 after buying an additional 1,226 shares in the last quarter. Franklin Resources Inc. grew its holdings in Alphatec by 2.0% in the 4th quarter. Franklin Resources Inc. now owns 64,774 shares of the medical technology company’s stock valued at $1,363,000 after buying an additional 1,299 shares in the last quarter. Oppenheimer Asset Management Inc. increased its stake in shares of Alphatec by 9.9% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 15,075 shares of the medical technology company’s stock worth $317,000 after acquiring an additional 1,353 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. increased its stake in shares of Alphatec by 157.1% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 2,571 shares of the medical technology company’s stock worth $54,000 after acquiring an additional 1,571 shares during the last quarter. Institutional investors and hedge funds own 66.35% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on ATEC shares. Stifel Nicolaus reduced their price target on Alphatec from $16.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday. Piper Sandler reissued an “overweight” rating and issued a $14.00 price objective (down from $25.00) on shares of Alphatec in a report on Wednesday, May 6th. Barclays cut their price objective on shares of Alphatec from $27.00 to $24.00 and set an “overweight” rating for the company in a research report on Thursday, May 7th. Lake Street Capital reissued a “buy” rating and issued a $15.00 price target on shares of Alphatec in a research note on Wednesday, May 6th. Finally, Needham & Company LLC cut their price target on shares of Alphatec from $25.00 to $14.00 and set a “buy” rating for the company in a report on Wednesday, May 6th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Alphatec has a consensus rating of “Moderate Buy” and an average price target of $17.46.

Insider Transactions at Alphatec

In other Alphatec news, Director Karen K. Mcginnis sold 6,050 shares of the company’s stock in a transaction dated Thursday, June 11th. The shares were sold at an average price of $8.01, for a total value of $48,460.50. Following the transaction, the director owned 94,671 shares of the company’s stock, valued at $758,314.71. This represents a 6.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 13.48% of the company’s stock.

Alphatec Stock Performance

Shares of Alphatec stock opened at $9.51 on Friday. Alphatec Holdings, Inc. has a 52 week low of $6.82 and a 52 week high of $23.29. The business’s fifty day simple moving average is $8.36 and its 200-day simple moving average is $12.28. The firm has a market cap of $1.46 billion, a PE ratio of -11.60 and a beta of 0.85. The company has a quick ratio of 1.12, a current ratio of 1.90 and a debt-to-equity ratio of 40.35.

Alphatec Profile

Alphatec Holdings, Inc (NASDAQ: ATEC) is a medical technology company focused on the design, development and commercialization of products for the surgical correction of degenerative spinal conditions. The company’s portfolio centers on interbody implants, biologics, fixation devices and surgical planning tools intended to improve patient outcomes in spinal fusion procedures. Alphatec’s flagship offerings include customizable interbody cages, bone graft materials and specialized instrumentation designed for minimally invasive and open spinal surgeries.

Founded as Alphatec Spine in 1985 and rebranded as Alphatec Holdings in 2018, the company has grown from a single-product organization into a multi-platform innovator in the spine market.